Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, destructiveHint. Description adds behavioral detail: fans across multiple sources, returns specific data points, notes soft-failure for patents (USPTO API sunset May 2025), and mentions it returns URIs. No contradictions; fully transparent.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is long but well-structured: starts with examples, then purpose statement, then detailed return list. Some repetition ('Names not supported' appears twice) but every sentence adds value. Could be slightly tightened but still effective.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

No output schema exists, so description must cover return values. It does so comprehensively: lists CIK, company name, filings with URIs, fundamentals (period_end descending), patents with sunset note, news, LEI. Also covers input constraints. Complete for agent usage.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, baseline 3. Description adds value by explaining the 'value' parameter can be ticker or zero-padded CIK, and reiterates that names are not supported with a pointer to resolve_entity. This actionable guidance lifts score to 4.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description starts with clear user query examples, then states 'full cross-source profile of a US public company in ONE parallel call.' It explicitly names the verb (research/profile) and resource (US public company). It distinguishes from siblings by saying 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups.'

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit when-to-use: when user asks for a holistic view of a US public company. It says 'ALWAYS PREFER over chaining' and also gives when-not: 'Names not supported — use resolve_entity first if you only have a name.' This clearly guides the agent on alternatives.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Several tool groups (ask_pipeworx/ask_pipeworx_grounded/deep_research, conditions/disease_names, polymarket_* family) have overlapping purposes, requiring careful reading of descriptions to differentiate. While many tools are conceptually distinct, the similarity within domains could lead to agent misselection.

Naming Consistency3/5

Naming is mostly snake_case but patterns vary: verb_noun (ask_pipeworx), noun_noun (entity_profile), single verb (forget, recall), and some adjectives (recent_changes). No consistent structure across the set, though individual names are descriptive.

Tool Count2/5

With 40 tools, the server is overly large for typical coherence. The tool count exceeds the 15–25 range deemed borderline, making it hard for agents to navigate and select efficiently.

Completeness4/5

The surface covers medical coding (ICD, LOINC, UCUM, drugs, procedures), financial data, prediction markets, memory, subscriptions, and meta-tools. Missing but minor elements (e.g., CPT codes) do not significantly hinder common workflows.